The sandbox: Parker Institute throws its research muscle behind gene therapy tech for destroying cancer cells
John Beadle and the big research team at PsiOxus have thought a lot about infiltrating the ranks of cancer cells, to go inside cells to cause their self-destruction with one of the industry’s leading “unarmed” oncolytc virus programs. But they’re also going one big step further, using their gene therapy tech to penetrate these cells to deliver weapons for their mass destruction. And they’re lining up some powerhouse allies at the Parker Institute for Cancer Immunotherapy to speed the work.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.